| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 125.20B | 118.68B | 92.86B | 90.71B | 68.23B | 42.06B |
| Gross Profit | 41.06B | 35.51B | 18.62B | 17.67B | 15.37B | 9.60B |
| EBITDA | 37.36B | 31.36B | 14.11B | 13.82B | 13.15B | 8.52B |
| Net Income | 15.80B | 12.29B | 3.62B | 5.20B | 4.74B | 2.27B |
Balance Sheet | ||||||
| Total Assets | 168.01B | 162.05B | 142.16B | 132.29B | 129.52B | 87.81B |
| Cash, Cash Equivalents and Short-Term Investments | 31.37B | 30.38B | 21.13B | 24.14B | 24.48B | 10.75B |
| Total Debt | 66.41B | 61.47B | 53.38B | 49.09B | 48.42B | 43.87B |
| Total Liabilities | 88.85B | 86.62B | 73.07B | 65.15B | 65.35B | 53.30B |
| Stockholders Equity | 76.94B | 73.16B | 67.14B | 65.48B | 62.59B | 33.06B |
Cash Flow | ||||||
| Free Cash Flow | -2.73B | 7.88B | 236.00M | 3.48B | 6.59B | -1.50B |
| Operating Cash Flow | 190.50M | 19.84B | 12.19B | 9.18B | 11.02B | 7.40B |
| Investing Cash Flow | -2.93B | -11.88B | -16.75B | -6.69B | -2.08B | -13.59B |
| Financing Cash Flow | 3.00B | 1.31B | 1.54B | -2.83B | -3.77B | 5.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥82.14B | 5.37 | ― | 2.77% | 24.61% | 185.90% | |
73 Outperform | ¥185.99B | 17.31 | 11.00% | 2.20% | 6.63% | -3.05% | |
73 Outperform | ¥27.84B | 7.02 | ― | 2.62% | -9.37% | 590.66% | |
73 Outperform | ¥396.08B | 25.33 | ― | 1.30% | 8.33% | 1.73% | |
66 Neutral | ¥7.46B | 16.59 | ― | 1.36% | 3.68% | -24.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥9.46B | 6.52 | ― | 3.34% | 7.12% | -43.68% |